NewzVille Desk
The 18th BRICS Summit has given a significant push to international cooperation in Traditional, Complementary and Integrative Medicine (TCIM), recognising its growing relevance to strengthening health systems and contributing towards Universal Health Coverage (UHC).
The key outcome of the New Delhi Declaration is the welcome accorded to the proposed establishment of a BRICS Expert Working Group on TCIM under the BRICS Health Track.
The proposed Working Group is envisaged as a platform for dialogue, collaboration and exchange among BRICS Member States, providing a structured mechanism for advancing cooperation in traditional medicine.
Union Minister of State (Independent Charge), Ministry of Ayush Prataprao Jadhav, highlighted, “The recognition of Traditional, Complementary and Integrative Medicine in the New Delhi Declaration is an important step towards strengthening global cooperation in traditional medicine. The proposed BRICS Expert Working Group will provide a meaningful platform for Member States to share knowledge, strengthen research and advance evidence-based approaches. India remains committed to taking forward Ayurveda and other traditional systems of medicine through scientific research, quality assurance and international collaboration, so that their potential can contribute to safe, effective and affordable healthcare.”
Secretary, Ministry of Ayush, Vaidya Rajesh Kotecha, informed, “The New Delhi Declaration marks an important step in advancing structured cooperation on Traditional, Complementary and Integrative Medicine among BRICS countries. The proposed Expert Working Group can provide a focused platform for sharing evidence, strengthening research collaboration and improving quality and regulatory approaches. India, through its Ayush ecosystem, is committed to contributing to this cooperation by promoting rigorous research and evidence-informed practices that can support safe, effective and affordable healthcare.”
The Declaration calls for greater cooperation in research on medicinal plants and herbal preparations used for therapeutic and preventive purposes. It recognises that the shared traditional pharmacopoeias of BRICS Member Countries can serve as a foundation for developing safe, effective and affordable therapeutic products.
